Adenosine deaminase deficiency can present with features of Omenn syndrome
Authors:
- Chaim M. RoifmanCRChaim M. Roifman
- Junyan ZhangJZJunyan Zhang
- Adelle AtkinsonAAAdelle Atkinson
- Eyal GrunebaumEGEyal Grunebaum
- Karen MandelKMKaren Mandel
- 1 April 2008
- journal article
- other
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 121 (4) , 1056-1058
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Mutations in the RNA component of RNase mitochondrial RNA processing might cause Omenn syndromeJournal of Allergy and Clinical Immunology, 2006
- Novel RAG1 Mutation in a Case of Severe Combined ImmunodeficiencyPediatrics, 2005
- Partial V(D)J Recombination Activity Leads to Omenn SyndromeCell, 1998
- Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: implications for evolution of a CpG hotspot and expression of a transduced ADA cDNAHuman Molecular Genetics, 1995
- Expansion of CD3+CD4−CD8− T cell population expressing high levels of IL-5 in Omenn's syndromeClinical and Experimental Immunology, 1994
- Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype.Journal of Clinical Investigation, 1993
- Novel T-Lymphocyte Population in Combined Immunodeficiency with Features of Graft-versus-Host DiseaseNew England Journal of Medicine, 1989
- Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.Proceedings of the National Academy of Sciences, 1978
- Familial Reticuloendotheliosis with EosinophiliaNew England Journal of Medicine, 1965